High use (4 or more times per week for four years or more) of acetominophen (Tylenol), a high-selling over-the-counter analgesic or non-steroidal anti-inflammatory drug (NSAID), is linked to a two-fold increased risk of certain blood cancers.
Journal of Clinical Oncology, May 2011
Comments
No comments yet :( Be the first to comment on this post!